{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:37:20Z","timestamp":1782887840086,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science & Engineering Research Board","doi-asserted-by":"crossref","award":["SB\/EMEQ-278\/2013, 29-10-2013"],"award-info":[{"award-number":["SB\/EMEQ-278\/2013, 29-10-2013"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12906-019-2532-6","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T14:03:09Z","timestamp":1559829789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ouabain potentiates the antimicrobial activity of aminoglycosides against Staphylococcus aureus"],"prefix":"10.1186","volume":"19","author":[{"given":"Neelam","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehlata","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-6296","authenticated-orcid":false,"given":"Antresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005210","volume":"4","author":"J Koziel","year":"2009","unstructured":"Koziel J, Maciag-Gudowska A, Mikolajczyk T, Bzowska M, Sturdevant DE, Whitney AR, Shaw LN, DeLeo FR, Potempa J. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One. 2009;4:e5210.","journal-title":"PLoS One"},{"key":"2532_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","volume":"30","author":"DV Duin","year":"2016","unstructured":"Duin DV, Paterson D. Multidrug resistant Bacteria in the community : Trends and Lessons Learned. Infect Dis Clin North Am. 2016;30:377\u201390.","journal-title":"Infect Dis Clin North Am"},{"key":"2532_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/CMR.00081-09","volume":"23","author":"MZ David","year":"2010","unstructured":"David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616\u201387.","journal-title":"Clin Microbiol Rev"},{"key":"2532_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jgar.2016.07.008","volume":"7","author":"R Sunagar","year":"2016","unstructured":"Sunagar R, Hegde NR, Archana GJ, Sinha AY. Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India. J Glob Antimicrobial Resist. 2016;7:46\u201352.","journal-title":"J Glob Antimicrobial Resist"},{"key":"2532_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nmni.2015.05.003","volume":"7","author":"C Bouchiat","year":"2015","unstructured":"Bouchiat C, El-Zeenni N, Chakrakodi B, Nagaraj S, Arakere G, Etienne J. Epidemiology of Staphylococcus aureus in Bangalore, India: emergence of the ST217 clone and high rate of resistance to erythromycin and ciprofloxacin in the community. New Microbes New Infect. 2015;7:15\u201320.","journal-title":"New Microbes New Infect"},{"key":"2532_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-4632.2004.02138.x","volume":"43","author":"U Nagaraju","year":"2004","unstructured":"Nagaraju U, Bhat G, Kuruvila M, Pai GS, Jayalakshmi BRP. Methicillin-resistant Staphylococcus aureus in community-acquired pyoderma. Int J Dermatol. 2004;43:412\u20134.","journal-title":"Int J Dermatol"},{"key":"2532_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4103\/0971-5916.91001","volume":"134","author":"V Thati","year":"2011","unstructured":"Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011;134:704\u20138.","journal-title":"Indian J Med Res"},{"key":"2532_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179767","volume":"12","author":"H Uematsu","year":"2017","unstructured":"Uematsu H, Yamashita K, Kunisawa S, Fushimi K, Imanaka Y. Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: retrospective database study of Japanese hospitals. PLoS One. 2017;12:e0179767.","journal-title":"PLoS One"},{"key":"2532_CR9","doi-asserted-by":"publisher","first-page":"98S","DOI":"10.1046\/j.1365-2672.92.5s1.5.x","volume":"92","author":"P Gilbert","year":"2002","unstructured":"Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? J Appl Microbiol. 2002;92:98S\u2013110S.","journal-title":"J Appl Microbiol"},{"key":"2532_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-6632.2011.06281.x","volume":"1241","author":"MR Kiedrowski","year":"2011","unstructured":"Kiedrowski MR, Horswill AR. New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci. 2011;1241:104\u201321.","journal-title":"Ann N Y Acad Sci"},{"key":"2532_CR11","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1128\/IAI.71.7.4206-4211.2003","volume":"71","author":"KE Beenken","year":"2003","unstructured":"Beenken KE, Blevins JS, Smeltzer MS. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun. 2003;71:4206\u201311.","journal-title":"Infect Immun"},{"key":"2532_CR12","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/IAI.65.9.3606-3614.1997","volume":"65","author":"K Ohlsen","year":"1997","unstructured":"Ohlsen K, Koller KP, Hacker J. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun. 1997;65:3606\u201314.","journal-title":"Infect Immun"},{"key":"2532_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep16407","volume":"5","author":"S Thangamani","year":"2015","unstructured":"Thangamani S, Mohammad H, Abushahba MFN, Hamed MI, Sobreira JPT, Hedrick VE, Paul LN, Seleem MN. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Sci Rep. 2015;5:article16407.","journal-title":"Sci Rep"},{"key":"2532_CR14","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","volume":"21","author":"W Younis","year":"2015","unstructured":"Younis W, Thangamani S, Seleem MN. Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. Curr Pharm Des. 2015;21:4106\u201311.","journal-title":"Curr Pharm Des"},{"key":"2532_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117664","volume":"12","author":"Y Hu","year":"2015","unstructured":"Hu Y, Liu A, Vaudrey J, Vaiciunaite B, Moigboi C, McTavish SM, Kearns A, Coates A. Combinations of \u03b2-lactam or aminoglycoside antibiotics with Plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus. PLoS One. 2015;12:e0117664.","journal-title":"PLoS One"},{"key":"2532_CR16","doi-asserted-by":"publisher","first-page":"article1195","DOI":"10.3389\/fmicb.2015.01195","volume":"6","author":"E Cunningham-Oakes","year":"2015","unstructured":"Cunningham-Oakes E, Soren O, Moussa E, Rathor G, Liu Y, Coates A, Hu Y. Nordihydroguaiaretic acid enhances the activities of aminoglycosides against methicillin- sensitive and resistant Staphylococcus aureus in vitro and in vivo. Front Microbiol. 2015;6:article1195.","journal-title":"Front Microbiol"},{"key":"2532_CR17","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1128\/AAC.03672-14","volume":"58","author":"DJ Hess","year":"2014","unstructured":"Hess DJ, Henry-Stanley MJ, Wells CL. Antibacterial synergy of glycerol Monolaurate and aminoglycosides in Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2014;58:6970\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"2532_CR18","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1128\/JCM.01106-10","volume":"48","author":"A Elemam","year":"2010","unstructured":"Elemam A, Rahimian J, Doymaz M. In vitro evaluation of antibiotic synergy for Polymyxin B-resistant Carbapenemase-producing Klebsiella pneumonia. J Clin Microbiol. 2010;48:3558\u201362.","journal-title":"J Clin Microbiol"},{"key":"2532_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/01.CIR.99.9.1265","volume":"99","author":"PJ Hauptman","year":"1999","unstructured":"Hauptman PJ, Kelly RA. Digitalis. Circulation. 1999;99:1265\u201370.","journal-title":"Circulation."},{"key":"2532_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0b013e32831101d1","volume":"27","author":"MG Nicholls","year":"2009","unstructured":"Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, Hilton PJ. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens. 2009;27:3\u20138.","journal-title":"J Hypertens"},{"key":"2532_CR21","doi-asserted-by":"crossref","unstructured":"Simonini M, Pozzoli S, Bignami E, Casamassima N, Messaggio E, Lanzani C, Frati E, Botticelli IM, Rotatori F, Alfieri O, Zangrillo A, Manunta P. Endogenous Ouabain: an old Cardiotonic steroid as a new biomarker of heart failure and a predictor of mortality after cardiac surgery. Biomed Res Int. 2015:article714793.","DOI":"10.1155\/2015\/714793"},{"key":"2532_CR22","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00196.2017","volume":"314","author":"MP Blaustein","year":"2018","unstructured":"Blaustein MP. The pump, the exchanger, and the holyspirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system. Am J Physiol Cell Physiol. 2018;314:C3\u2013C26.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2532_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/B978-0-12-394305-7.00002-1","volume":"294","author":"E Silva","year":"2012","unstructured":"Silva E, Soares-da-Silva P. New insights into the regulation of Na+K+-ATPase by Ouabain. Int Rev Cell Mol Biol. 2012;294:99\u2013132.","journal-title":"Int Rev Cell Mol Biol"},{"key":"2532_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","volume":"10","author":"GR de Lores Arnaiz","year":"2014","unstructured":"de Lores Arnaiz GR, Ordieres MGL. Brain Na+, K+-ATPase activity in aging and disease. Int J Biomed Sci. 2014;10:85\u2013102.","journal-title":"Int J Biomed Sci"},{"key":"2532_CR25","doi-asserted-by":"publisher","first-page":"F897","DOI":"10.1152\/ajprenal.00095.2011","volume":"301","author":"AN Nguyen","year":"2011","unstructured":"Nguyen AN, Jansson K, S\u00e1nchez G, Sharma M, Reif GA, Wallace DP, Blanco G. Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation. Am J Physiol Renal Physiol. 2011;301:F897\u2013906.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2532_CR26","doi-asserted-by":"publisher","first-page":"article107","DOI":"10.3389\/fphys.2016.00107","volume":"7","author":"J Venugopal","year":"2016","unstructured":"Venugopal J, Blanco G. Ouabain enhances ADPKD cell apoptosis via the intrinsic pathway. Front Physiol. 2016;7:article107.","journal-title":"Front Physiol"},{"key":"2532_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1248\/bpb.33.743","volume":"33","author":"ZW Xu","year":"2010","unstructured":"Xu ZW, Wang FM, Gao MJ, Chen XY, Hu WL, Xu RC. Targeting the Na(+)\/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. Biol Pharm Bull. 2010;33:743\u201351.","journal-title":"Biol Pharm Bull"},{"key":"2532_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/cbr.2011.1138","volume":"27","author":"T Ozdemir","year":"2012","unstructured":"Ozdemir T, Nar R, Kilinc V, Alacam H, Salis O, Duzgun A, Gulten S, Bedir A. Ouabain targets the unfolded protein response for selective killing of HepG2 cells during glucose deprivation. Cancer Biother Radiopharm. 2012;27:457\u201363.","journal-title":"Cancer Biother Radiopharm"},{"key":"2532_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/j.1742-1241.2010.02395.x","volume":"64","author":"H Furstenwerth","year":"2010","unstructured":"Furstenwerth H. Ouabain - the insulin of the heart. Int J Clin Pract. 2010;64:1591\u20134.","journal-title":"Int J Clin Pract"},{"key":"2532_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3923\/jm.2006.203.209","volume":"1","author":"M Martins","year":"2006","unstructured":"Martins M, Viveiros M, Ordway D, Kristiansen JE, Molnar J, Amaral L. Reserpine, Ouabain and the Calcium Channel blocker verapamil, cause intracellular killing of Staphylococcus aureus. Res J Microbiol. 2006;1:203\u20139.","journal-title":"Res J Microbiol"},{"key":"2532_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5582\/ddt.2018.01042","volume":"12","author":"S Kumar","year":"2018","unstructured":"Kumar S, Kumar A, Kaushal M, Kumar P, Mukhopadhayay K, Kumar A. Fungal-derived xenobiotic exhibits antimicrobial and antibiofilm activity against Staphylococcus aureus. Drug Discov. 2018;12:214\u201323.","journal-title":"Drug Discov"},{"key":"2532_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BJ20120190","volume":"445","author":"A Mandal","year":"2012","unstructured":"Mandal A, Kumar A, Singh A, Lynn AM, Kapoor K, Prasad R. A key structural domain of the Candida albicans Mdr1 protein. Biochem J. 2012;445:313\u201322.","journal-title":"Biochem J"},{"key":"2532_CR33","unstructured":"El-Azizi M. Novel microdilution method to assess double and triple antibiotic combination therapy in vitro. Int J Microbiol. 2011:article4612021."},{"key":"2532_CR34","first-page":"570","volume":"10","author":"M Sharma","year":"2010","unstructured":"Sharma M, Manoharlal R, Negi AS, Prasad R. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res. 2010;10:570\u20138.","journal-title":"FEMS Yeast Res"},{"key":"2532_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan G, Bayram A, Zer Y, Balci I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005;43:140\u20133.","journal-title":"J Clin Microbiol"},{"key":"2532_CR36","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.1021\/bi0345900","volume":"42","author":"S Jha","year":"2003","unstructured":"Jha S, Karnani N, Dhar SK, Mukhopadhayay K, Shukla S, Saini P, Mukhopadhayay G, Prasad R. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker a is critical for ATP hydrolysis. Biochem. 2003;42:10822\u201332.","journal-title":"Biochem."},{"key":"2532_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/cbic.201600532","volume":"18","author":"D Borselli","year":"2017","unstructured":"Borselli D, Blanchet M, Bolla J, Muth A, Skruber K, Otto P, Brunel JM. Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative Bacteria. Chem Bio Chem. 2017;18:276\u201383.","journal-title":"Chem Bio Chem"},{"key":"2532_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.21065\/19204159.6.3.145","volume":"6","author":"S Naveed","year":"2014","unstructured":"Naveed S, Shah SN, Qamar F, Waheed N, Nazeer S. Simple UV spectrophotometric assay of new formulation gentamycin. J App Pharm. 2014;6:407\u201310.","journal-title":"J App Pharm"},{"key":"2532_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.bbamem.2010.05.017","volume":"1798","author":"A Kumar","year":"2010","unstructured":"Kumar A, Shukla S, Mandal A, Shukla S, Ambudkar S, Prasad R. Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and non-interchangeable. BBA Memb. 2010;1798:1757\u201366.","journal-title":"BBA Memb"},{"key":"2532_CR40","doi-asserted-by":"publisher","unstructured":"Arya R, Ravikumar R, Santhosh RS, Princy SA. SarA based novel therapeutic candidate against Staphylococcus aureus associated with vascular graft infections. Front Microbiol. 2015;6. https:\/\/doi.org\/10.3389\/fmicb.2015.00416 .","DOI":"10.3389\/fmicb.2015.00416"},{"key":"2532_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep13412","volume":"5","author":"L Chopra","year":"2015","unstructured":"Chopra L, Singh G, Jena KK, Sahoo DK. Sonorensin: a new bacteriocin with potential of an anti-biofilm agent and a food biopreservative. Sci Rep. 2015;5:article13412.","journal-title":"Sci Rep"},{"key":"2532_CR42","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1128\/AAC.01180-12","volume":"56","author":"E Mataraci","year":"2012","unstructured":"Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin resistance Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2012;56:6366\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"2532_CR43","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak M J, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"2532_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653\u201365.","journal-title":"N Engl J Med"},{"key":"2532_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jac\/dkr510","volume":"67","author":"G Mitchell","year":"2012","unstructured":"Mitchell G, Lafrance M, Boulanger S, Seguin DL, Guay I, Gattuso M, Marsault E, Bouarab K, Malouin F. Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. J Antimicrob Chemother. 2012;67:559\u201368.","journal-title":"J Antimicrob Chemother"},{"key":"2532_CR46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473:216\u201320.","journal-title":"Nature."},{"key":"2532_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1099\/jmm.0.068130-0","volume":"63","author":"MJ Henry-Stanley","year":"2014","unstructured":"Henry-Stanley MJ, Hess DJ, Wells CL. Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol. 2014;63:861\u20139.","journal-title":"J Med Microbiol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2532-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2532-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2532-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:19:14Z","timestamp":1694935154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2532-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2532-6","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}